Oculis Holding AG Warrants

NASDAQ:OCSAW USA Biotechnology
Market Cap
$162.21K
Market Cap Rank
#39934 Global
#12984 in USA
Share Price
$16.43
Change (1 day)
+0.00%
52-Week Range
$3.90 - $18.50
All Time High
$18.50
Categories
Companies in USA Biotechnology
About

Oculis Holding AG, a biopharmaceutical company, develops novel topical treatments for ophthalmic diseases for both back- and front-of-the-eye. Its product candidates in development includes OCS-01, a topical retinal candidate for diabetic macular edema; OCS-02, a topical biologic candidate for dry eye disease; and OCS-05, a disease modifying candidate for acute optic neuritis and other neuro-opht… Read more

Oculis Holding AG Warrants (OCSAW) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of June 2024: -0.120x

Based on the latest financial reports, Oculis Holding AG Warrants (OCSAW) has a cash flow conversion efficiency ratio of -0.120x as of June 2024.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-13.52 Million) by net assets ($112.83 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Oculis Holding AG Warrants - Cash Flow Conversion Efficiency Trend (2020–2023)

This chart illustrates how Oculis Holding AG Warrants's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Oculis Holding AG Warrants Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Oculis Holding AG Warrants ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Flamemaster Corporation
PINK:FAME
 		N/A
LOGAN RIDGE FIN. DL-01
F:0XL0
 		N/A
Green Cross Holdings Corp. Pfd. Series 2
KQ:005257
 		N/A
rad Fic Firf Invest Infra Cdi Cp Resp Ltda
SA:BINC11
 		N/A
APXR11
SA:APXR11
 		N/A
Federal Home Loan Mortgage Corporation PFD 5.1% SAL
OTCQB:FREJO
 		0.066x
Target Global Acquisition I Corp. Warrant
NASDAQ:TGAAW
 		-0.007x
Wealth In HP InvLaDK OblAkk-KL
CO:WEIHPILDKOAKKKL
 		N/A

Annual Cash Flow Conversion Efficiency for Oculis Holding AG Warrants (2020–2023)

The table below shows the annual cash flow conversion efficiency of Oculis Holding AG Warrants from 2020 to 2023.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2023-12-31 $93.73 Million $-53.84 Million -0.574x -324.51%
2022-12-31 $-97.99 Million $-25.07 Million 0.256x +12.82%
2021-12-31 $-60.95 Million $-13.82 Million 0.227x -17.69%
2020-12-31 $-43.65 Million $-12.03 Million 0.276x --